Navigation Links
HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy

According to researchers, Breast Cancer Patients with HER-2 Positive tumor who do not respond well to Herceptin alone could benefit// with a combination of drug Herceptin and one or more P13K-inhibiting agents.

The research team at the University of Texas M.D. Anderson Cancer Center in Houston is due to conduct anther trial, after having successfully tested it on mice. The second stage of the trial, will involve severe cancer cases where the disease has advanced in spite of Herceptin Treatment in Her2 positive patients.

Study author Dr. Dihua Yu, a professor in the department of surgical oncology said 'More than half of patients with HER2-positive tumors don't respond to Herceptin as a single agent, and our research has shown us why that is and what might be done to help these patients. If this drug cocktail shows benefit, we hope to be able to identify those patients who won't respond to Herceptin before they start the treatment, and offer them a new and beneficial drug combination. Patients who don't respond to Herceptin have worrisome outcomes, so we hope this strategy will help them.'

There is ample indication, supported by successful outcomes of previous research, which has provided the impetus to a combination treatment for aggressive breast cancers.


'"/>




Page: 1

Related medicine news :

1. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
2. The Positive Effects Of A Healthy Lifestyle
3. The Positive Effects Of A Healthy Lifestyle
4. Positive Thinking
5. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
6. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
7. HIV Positive People Touching 60,000 In UK
8. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
9. HIV Positive Men in Singapore Exposed
10. Positive Emotions lead To Life Longevity
11. New Fund Launched To Help HIV Positive Women
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to feel uncomfortable ... safer than regular municipal or well water. The recent experience with lead contaminated water ... go a long way toward increasing public acceptance of recycled waste water as drinking ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... recently announced the debut of their latest mobile kitchen model, featuring customizable stainless ... with modern, high-volume commercial kitchens for use anywhere in the U.S. Many of ...
(Date:2/5/2016)... ... February 05, 2016 , ... –This week, Atascadero water heater company ... a tankless water heater. To view the report, click here or see ... While each has their pros and cons, the type chosen is almost entirely up ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 For hospitals considering ... those already participating in the program, the Health Resources ... to as the , Mega-Guidance , could have significant ... is published in September 2016. Essential Insights ... Service Marketing , summarizes the Mega-Guidance,s key proposed changes, ...
(Date:2/4/2016)... Feb. 4, 2016  The Senior Care Pharmacy ... Reform Committee Chairman Jason Chaffetz (R-UT) ... today,s hearing , "Developments in the Prescription ... and growing questions about abusive pharmacy benefit manager ... (R-UT) and Ranking Member Elijah Cummings (D-MD) are ...
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
Breaking Medicine Technology: